From the Journals
FDA & Government News

PrEP Users With AUD Under-Treated, Study Finds

Share

6 Key Takeaways
  • 1

    15% of patients initiating PrEP had an alcohol use disorder diagnosis within 6 months.

  • 2

    Only

  • 3

    46% of patients with AUD received an FDA-approved medication.

  • 4

    The underdiagnosis of AUD prior to PrEP initiation and undertreatment following initiation was highlighted.

  • 5

    The study emphasized integrating mental health assessments into regular care alongside PrEP services.

  • 6

    Improved screening and access to evidence-based treatments for AUD in this population is necessary to support PrEP adherence and HIV prevention efforts.

Original Source(s)

Related Content